Cardiovascular Disease Doctors in Murrieta, CA Accepting Medicare

7 Cardiovascular Disease doctors found. Showing 1 - 7

Herman David Lu, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25405 Hancock Ave, Suite 216, Murrieta, CA 92562 Phone: 951-698-4600    Fax: 951-514-2542

Lance S Reinherz, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25405 Hancock Ave, #216, Murrieta, CA 92562 Phone: 951-698-4600

Manila Zaman, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 29995 Technology Dr, Suite 302, Murrieta, CA 92563 Phone: 951-445-4347    Fax: 951-445-4389

Jeffrey C Chung, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25405 Hancock Ave, #216, Murrieta, CA 92562 Phone: 951-698-4600

Mark M Dang, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25405 Hancock Ave, Suite 216, Murrieta, CA 92562 Phone: 951-698-4600

Ransi M Somaratne, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 25405 Hancock Ave, Suite 216, Murrieta, CA 92562 Phone: 951-698-4609    Fax: 951-698-4605

Dr. Steve Hui Jin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25405 Hancock Ave Ste 216, Murrieta, CA 92562 Phone: 951-698-4600    Fax: 951-893-5131

News Archive

Novel molecular targeting technologies to deliver gene-silencing therapy

Researchers have combined novel molecular targeting technologies to deliver gene-silencing therapy specifically to tumor cells shielded by a normally impermeable obstacle, the blood brain barrier.

Adding immune oncology drug to chemotherapy improves response in subset of breast cancer patients

In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.

BSD Medical announces results from BSD-2000 hyperthermia system study on pancreatic cancer

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced the publication of results from a clinical study on advanced pancreatic cancer using the BSD-2000 Hyperthermia System (BSD-2000).

Patients with pulmonary embolism experience long term limitations to physical stamina

A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) - a blood clot in the lung - experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life.

Health IT legislation should allow portability for electronic health records

"Steps are now under way to bring ... lifesaving" electronic health records to all hospitals and physician offices in the U.S., but "Congress is considering a bill that would make it harder to allow your information to follow you throughout your health care treatment," former National Coordinator for Health Information Technology David Brailer writes in a New York Times opinion piece.

Read more Medical News

› Verified 6 days ago